Related Experiment Videos
Thalassemias: simple screening for hereditary anemias
1Columbia University School of Nursing, New York.
The Nurse Practitioner
|February 1, 1992
Summary
Thalassemia minor, a carrier state for a fatal blood disease, can be identified through routine blood tests. Early diagnosis of thalassemia minor prevents unnecessary anemia treatment and guides reproductive health decisions.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Thalassemias are the most common inherited blood disorders globally.
- Thalassemia major is a severe, often fatal condition, while thalassemia minor represents the carrier state.
- 100,000 children worldwide are born with thalassemia major annually.
Purpose of the Study:
- To highlight the importance of identifying thalassemia minor in clinical practice.
- To emphasize the role of early diagnosis in preventing unnecessary medical interventions.
- To inform healthcare practitioners about preconception counseling and screening responsibilities.
Main Methods:
- Evaluation of routine red-blood-cell indices for potential identification.
- Confirmation of diagnosis through hemoglobin A2 (Hgb A2) evaluation.
Main Results:
- Thalassemia minor can be easily identified using standard red-blood-cell indices.
- Hgb A2 evaluation confirms the diagnosis of thalassemia minor.
- Knowledge of carrier status allows for avoidance of unnecessary anemia treatments.
Conclusions:
- Early identification and diagnosis of thalassemia minor are crucial for patient management.
- Healthcare providers must educate patients on carrier status, preconception counseling, and partner screening.
- Proactive screening and referral for potential congenital diseases are essential for reproductive-aged individuals.